Expression and clinical significance of periostin in oral lichen planus

Zhang,Zhi‑Rui; Chen,Li‑Ya; Qi,Hong‑Yan; Sun,Shao‑Hua

doi:10.3892/etm.2018.6029

Expression and clinical significance of periostin in oral lichen planus

Authors:
- Zhi‑Rui Zhang
- Li‑Ya Chen
- Hong‑Yan Qi
- Shao‑Hua Sun
View Affiliations

Affiliations: Department of Stomatology, First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Department of Pathology, First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China
Published online on: April 3, 2018 https://doi.org/10.3892/etm.2018.6029
Pages: 5141-5147

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral lichen planus (OLP) is a chronic inflammatory lesion involving the oral mucosa, which has a high likelihood of progressing to cancer. The present study investigated the periostin expression in the mucosa and serum of patients with OLP and its correlation with serum cytokines. A total of 117 patients with OLP and 110 healthy controls were included in the study. The protein expression of periostin were measured in the OLP and normal oral mucosa by immunohistochemistry. ELISA was performed to measure the serum levels of periostin, tumour necrosis factor‑α (TNF‑α), interleukin (IL)‑6, interferon‑γ (IFN‑γ), IL‑4 and thymic stromal lymphopoietin (TSLP). Compared with the control group the OLP group had a significantly increased number of cases with high periostin expression in the oral mucosa and a significantly increased serum periostin level (P<0.05). Among all 117 OLP subjects, high periostin expression was associated with higher serum IL‑6, TNF‑α, TSLP and tissue mast cell density. High periostin expression was also significantly associated with a lower IFN‑γ/IL‑4 ratio (P<0.05). The present study concluded that periostin expression was increased in the oral mucosa and serum of patients with OLP and was associated with inflammatory response, T helper 2 cytokine‑predominant immune imbalance, increased mast cell count and TSLP. The modulation of periostin may represent an attractive novel therapeutic target.

View Figures

View References

1	Alrashdan MS, Cirillo N and McCullough M: Oral lichen planus: A literature review and update. Arch Dermatol Res. 308:539–551. 2016. View Article : Google Scholar : PubMed/NCBI
2	Krupaa RJ, Sankari SL, Masthan KM and Rajesh E: Oral lichen planus: An overview. J Pharm Bioallied Sci. 7 Suppl 1:S158–S161. 2015. View Article : Google Scholar : PubMed/NCBI
3	Eversole LR: Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg. 16:284–294. 1997. View Article : Google Scholar : PubMed/NCBI
4	Fitzpatrick SG, Hirsch SA and Gordon SC: The malignant transformation of oral lichen planus and oral lichenoid lesions: A systematic review. J Am Dent Assoc. 145:45–56. 2014. View Article : Google Scholar : PubMed/NCBI
5	Kurago ZB: Etiology and pathogenesis of oral lichen planus: An overview. Oral Surg Oral Med Oral Pathol Oral Radiol. 122:72–80. 2016. View Article : Google Scholar : PubMed/NCBI
6	Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, et al: Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 25:11131–11144. 2005. View Article : Google Scholar : PubMed/NCBI
7	Ratajczak-Wielgomas K and Dziegiel P: The role of periostin in neoplastic processes. Folia Histochem Cytobiol. 53:120–132. 2015. View Article : Google Scholar : PubMed/NCBI
8	Ruan K, Bao S and Ouyang G: The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 66:2219–2230. 2009. View Article : Google Scholar : PubMed/NCBI
9	Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC and Hu B: Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance. Onco Targets Ther. 9:5133–5142. 2016. View Article : Google Scholar : PubMed/NCBI
10	Madhuri AR, Alka KD and Ramakanth N: Mast cells are increased in leukoplakia, oral submucous fibrosis, oral lichen planus and oral squamous cell carcinoma. JOMFP. 11:18–22. 2007.
11	Choi P, Jordan CD, Mendez E, Houck J, Yueh B, Farwell DG, Futran N and Chen C: Examination of oral cancer biomarkers by tissue microarray analysis. Arch Otolaryngol Head Neck Surg. 134:539–546. 2008. View Article : Google Scholar : PubMed/NCBI
12	Siriwardena BS, Kudo Y, Ogawa I, Kitagawa M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M and Takata T: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer. 95:1396–1403. 2006. View Article : Google Scholar : PubMed/NCBI
13	Agha-Hosseini F, Sheykhbahaei N and SadrZadeh-Afshar MS: Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: A literature review. J Contemp Dent Pract. 17:692–701. 2016. View Article : Google Scholar : PubMed/NCBI
14	Kaur J and Jacobs R: Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, andoral submucous fibrosis. J Korean Assoc Oral Maxillofac Surg. 41:171–175. 2015. View Article : Google Scholar : PubMed/NCBI
15	Liu Y, Messadi DV, Wu H and Hu S: Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses. 75:492–494. 2010. View Article : Google Scholar : PubMed/NCBI
16	Lu R, Zhang J, Sun W, Du G and Zhou G: Inflammation-related cytokines in oral lichen planus: An overview. J Oral Pathol Med. 44:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
17	Liu AY, Zheng H and Ouyang G: Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol. 37:150–156. 2014. View Article : Google Scholar : PubMed/NCBI
18	Koh SJ, Choi Y, Kim BG, Lee KL, Kim DW, Kim JH, Kim JW and Kim JS: Matricellular protein periostin mediates intestinal inflammation through the activation of nuclear factor κB signaling. PLoS One. 11:e01496522016. View Article : Google Scholar : PubMed/NCBI
19	Taniguchi K, Arima K, Masuoka M, Ohta S, Shiraishi H, Ontsuka K, Suzuki S, Inamitsu M, Yamamoto KI, Simmons O, et al: Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop. J Invest Dermatol. 134:1295–1304. 2014. View Article : Google Scholar : PubMed/NCBI
20	Neurath MF, Finotto S and Glimcher LH: The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 8:567–573. 2002. View Article : Google Scholar : PubMed/NCBI
21	Liu WZ, He MJ, Long L, Mu DL, Xu MS, Xing X, Zeng X, Liao G, Dan HX and Chen QM: Interferon-γ and interleukin-4 detected in serum and saliva from patients with oral lichen planus. Int J Oral Sci. 6:22–26. 2014. View Article : Google Scholar : PubMed/NCBI
22	Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, Toda S, Inagaki N, Kurihara Y, Hayashida S, et al: Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 122:2590–2600. 2012. View Article : Google Scholar : PubMed/NCBI
23	Sharma R, Sircar K, Singh S and Rastogi V: Role of mast cells in pathogenesis of oral lichen planus. J Oral Maxillofac Pathol. 15:267–271. 2011. View Article : Google Scholar : PubMed/NCBI
24	Pujari R and Vidya N: Mast cell density in oral submucous fibrosis: A possible role in pathogenesis. Int J Health Sci (Qassim). 7:23–29. 2013. View Article : Google Scholar : PubMed/NCBI
25	Huang Y, Liu W, Xiao H, Maitikabili A, Lin Q, Wu T, Huang Z, Liu F, Luo Q and Ouyang G: Matricellular protein periostin contributes to hepatic inflammation and fibrosis. Am J Pathol. 185:786–797. 2015. View Article : Google Scholar : PubMed/NCBI
26	Kim DW, Kulka M, Jo A, Eun KM, Arizmendi N, Tancowny BP, Hong SN, Lee JP, Jin HR, Lockey RF, et al: Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps. J Allergy Clin Immunol. 139:1692–1695.e6. 2017. View Article : Google Scholar : PubMed/NCBI
27	Ziegler SF, Roan F, Bell BD, Stoklasek TA, Kitajima M and Han H: The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 66:129–155. 2013. View Article : Google Scholar : PubMed/NCBI
28	Sun M, Tan W, Liu S, Liu G, Zhang X, Wang N, Qu X and Wei F: In situ expression and serum level of thymic stromal lymphopoietin in oral lichen planus. J Oral Pathol Med. 43:740–745. 2014. View Article : Google Scholar : PubMed/NCBI
29	Akasaki S, Matsushita K, Kato Y, Fukuoka A, Iwasaki N, Nakahira M, Fujieda S, Yasuda K and Yoshimoto T: Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways. Int Immunol. 28:65–76. 2016.PubMed/NCBI
30	Takahashi N, Sugaya M, Suga H, Oka T, Kawaguchi M, Miyagaki T, Fujita H and Sato S: Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma. Cancer Res. 76:6241–6252. 2016. View Article : Google Scholar : PubMed/NCBI